The ability of several types of immune cells from C57BL/6J-mice (B6) and A/J-mice and their acetylator congenic strains (B6.A-NatS and A.B6-NatR, respectively) to metabolize aminofluorene (153786) (AF) and form DNA-AF adducts was examined. Mononuclear leukocytes (MNL) metabolized AF to its acetylated form 2-acetylaminofluorene (53963) (AAF). MNL from the rapid acetylator strain, B6, produced twice as much AAF as the MNL from the slow acetylator strain, B6.A-NatS. Increasing concentrations of AF in the culture media resulted in the increased production of AAF except at 100 micromolar AF. Likewise, increasing the amount of time the cells were exposed to AF increased the production of AAF. Para-aminobenzoic-acid (150130) (PABA) was more readily acetylated than AF and the differences in the amount of acetylated PABA between rapid and slow acetylator strains were significant. Both lymphocytes and monocytes acetylated AF but lymphocytes had a greater acetylating activity per one million cells than monocytes. High performance liquid chromatography analysis of AF metabolites of MNL from B6 and B6.A-NatS-mice only showed peaks corresponding to AF and AAF. Metabolites from A/J and A.B6-NatR- mice showed additional peaks which may be oxidation products. DNA adduct formation was two to three times higher in the rapid acetylator strains of mice, 0.8 to 3.5 picomoles of adduct per milligram of DNA, than in the slow acetylator strains, 0.79 picomoles of adduct per microgram of DNA.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.